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Abstract In a minority of cases, the natural history of
migraine without aura (MO) is characterised over time by its
evolution into a form of chronic migraine (CM). In order to
detect the possible factors predicting this negative evolution of
MO, we searched in our Headache Centre files for all clinical
records that met the following criteria: (a) first visit between
1976 and 1998; (b) diagnosis of MO or of common migraine at
the first observation, with or without association with other
primary headache types; (c)\15 days per month of migraine
at the first observation; and (d) at least one follow-up visit at
least 10 years after the first visit. The patients thus identified
were then divided into two groups based on a favourable/
steady evolution (Group A: n = 243, 195 women and 48 men)
or an unfavourable evolution (Group B: n = 72, 62 women
and 10 men) of their migraine over time. In the two groups, we
compared various clinical parameters that were present at the
first observation or emerged at the subsequent follow-up vis-
its. The parameters that were statistically significantly more
frequent in Group B—and can therefore be considered pos-
sible negative prognostic factors—were: (a) C10 days per
month of migraine at the first observation; (b) presence of
depression at the first visit in males; and (c) onset of depression
or arterial hypertension after the first observation but before
transformation to CM in females. Based on these findings, in
MO patients the high frequency of migraine attacks, comor-
bidity with depression, and the tendency to develop arterial
hypertension should require particular attention and careful
management to prevent evolution into CM.
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Introduction
Mean age at onset of migraine without aura (MO) is about
20 years. Onset may occur as early as in childhood, but
very rarely does over 50. Around this age, most patients see
that their migraine symptoms decrease and sometimes even
resolve completely. In contrast, in a minority, but not
negligible number, of patients, MO worsens over time,
changing some of its previous clinical features and espe-
cially increasing in frequency until there are no more free
intervals between attacks. Thus, MO is gradually trans-
formed from a typical attack-like headache to a so-called
chronic headache.
Several reports have been published on this subject in
the literature. However, there is still no consensus of
opinion on: (a) the type of headache that occurs in these
patients; and (b) the factors that may favour MO worsening
over time. We therefore tried to help clarify this issue by
performing a review of the broad case series of patients
followed over the years at our Headache Centre. We report
here the preliminary data of our study. The final data will
be presented in a future publication.
Patients and methods
We accessed the University of Parma Headache Centre
files and took all clinical records of patients that met the
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following requirements: (a) first visit between 1976 and
1998; (b) diagnosis of MO or of common migraine at the
first observation, with or without association with other
primary headache types; (c) \15 days per month of
migraine at the first observation; and (d) at least one fol-
low-up visit at least 10 years after the first visit.
The 348 patients (286 women and 62 men) thus iden-
tified were divided into groups based on the diagnoses
made at the subsequent visits, and particularly the diag-
nosis made during the most recent visit at the Centre.
Diagnoses were established according to the criteria of the
International Classification of Headache Disorders, 2nd
Edition (ICHD-II) of 2004 [1] and its 2006 revision
(ICHD-IIR) [2].
The MO patterns that the 348 patients exhibited over the
years varied widely, not only from patient to patient, but
also within the same patient showing a course of alternat-
ing improvement and worsening. For that reason, in order
to compare patients with a steady or favourable evolution
of MO over time to patients with an unfavourable evolu-
tion, we excluded 33 patients (29 women and four men)
who over the years showed a cyclically fluctuating
migraine pattern or developed a new form of headache that
might not necessary be interpreted as an evolution of their
original MO.
The remaining 315 patients (257 women and 58 men)
were divided into two groups based on a steady/favourable
evolution (Group A: n = 243, 195 women and 48 men) or
an unfavourable evolution (Group B: n = 72, 62 women
and 10 men) of their migraine over time. In each of the two
groups we compared not only the clinical features of MO
that were originally present at the first visit, but also several
parameters related to the patients’ family, physiological,
past, and recent medical histories, both at the first visit and
at the subsequent follow-up visits. Statistical analysis was
performed using Student’s t test and the v2 test.
Results
Mean age at the first observation of the 315 patients
included in the study was 32.0 ± 11.2 years, with no sig-
nificant differences between the 257 women (32.1 ±
11.1 years) and the 58 men (31.6 ± 11.9 years). In the 72
patients with an unfavourable MO evolution, mean age at
the first observation was older (Group B: 35.3 ± 11.6
years), though in a non-statistically significant way, than in
the 243 patients with a steady/favourable evolution (Group
A: 30.5 ± 11.1 years). The difference was more marked in
men (38.7 ± 8.8 vs. 30.1 ± 11.8) than in women (34.8 ±
11.9 vs. 30.6 ± 10.9).
No statistically significant differences were found
between Group A and Group B in age at the last
observation (46.0 ± 11.5 and 52.2 ± 12.5, respectively),
the number of years of observation (15.8 ± 4.4 and
15.0 ± 4.8), and the number of follow-up visits (3.8 ± 3.6
and 5.0 ± 4.8).
No significant differences were found between the two
groups in age at onset of MO, family history of migraine,
pain location, and duration of attacks at the time of the first
observation.
If we exclude three patients in Group A (two women and
one man) with a highly variable number of MO days per
month and 12 patients—eight in Group A (seven women
and one man) and four in Group B (three women and one
man)—with no certain data in their clinical records about
the number of MO days per month, the remaining 232
patients in Group A (186 women and 46 men) and the
remaining 68 patients in Group B (59 women and nine
men) showed a statistically significant difference in the
number of MO days per month at the time of the first
observation (Table 1).
In the patients’ medical histories reported at the first
observation, depression was more statistically significantly
present (p \ 0.05) in Group B men (6/9 corresponding to
66.7 %) than in Group A men (10/48 corresponding to
20.8 %).
Among the diseases that were reported at the subsequent
visits but occurred before MO ‘‘chronification’’, Group B
versus Group A women showed a statistically significantly
higher rate of depression (27/62 corresponding to 43.5 %
vs. 26/195 corresponding to 13.3 %, p \ 0.01) and arterial
hypertension (24/62 corresponding to 38.7 % vs. 35/195
corresponding to 17.9 %, p \ 0.01).
No statistically significant differences were found
between the two groups in the presence of other diseases
(head injury, hypo- or hyper-thyroidism, colitis, allergy,
insomnia, anxiety, and panic attack disorder), either at the
time of the first observation or later.
Table 1 Number of days of migraine per month at the first visit
B5 days per
month
6 to 10 days per
month
11 to 15 days per
month
Group A
M 20 (41.7 %) 19 (39.6 %) 7 (14.6 %)
F 83 (42.6 %) 59 (30.3 %) 44 (22.6 %)
Total 103 (42.4 %) 78 (32.1 %) 51 (21.0 %)
Group B
M 1 (10.0 %) 3 (30.0 %) 5 (50.0 %)
F 20 (32.3 %) 15 (24.2 %) 24 (38.7 %)
Total 21 (29.2 %) 18 (25.0 %) 29 (40.3 %)
11–15 days of MO per month versus B10 days of MO per month:
Group A versus Group B: p \ 0.01 for the total sample; p \ 0.05 for
both men and women
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Conclusions
Our data analysis indicates that a high number of MO days
per month, comorbidity with depression and susceptibility
to arterial hypertension in women represent unfavourable
prognostic factors for a possible ‘‘chronification’’ of MO.
Therefore, it is extremely important that the presence of
these elements in all MO subjects be investigated with the
utmost care. If present, they should be managed in the most
appropriate way in order to prevent migraine from turning
chronic.
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